Flash Finance

Camlin Fine Sciences LimitedCAMLINFINECorporate

Chemicals Latest results: Jun 2026 15 quarters of data
Consolidated Standalone
₹95.09
MCap ₹1,827 Cr
Camlin Fine Sciences Limited — Stock analysis & AI research Camlin Fine Sciences Limited — Seasonality — best & worst months Camlin Fine Sciences Limited — Technical indicators & charts Camlin Fine Sciences Limited — Technical setup — score, trend, support & resistance Camlin Fine Sciences Limited — Live exchange announcements
📈 MACD Bullish Crossover📈 Strong Trend Stocks (ADX > 25)📈 Multi-Timeframe Bearish Stocks📈 Unusual Volume Stocks 🏭 Chemicals sector
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹222 Cr
Sales · Jun 2026
+16.2% YoY
₹7 Cr
Operating Profit · Jun 2026
+45.7% YoY
3.1%
OPM % · Jun 2026
+29.2% YoY
₹-12 Cr
Net Profit · Jun 2026
-15.3% YoY
₹-0.64
EPS · Jun 2026
-12.3% YoY

📝 Camlin Fine Sciences Limited — results explained

Quarter ended June 2026 (Q1 FY27)

Camlin Fine Sciences Limited reported revenue of ₹222 crore for the quarter ended June 2026 (Q1 FY27), up 16.2% from ₹191 crore in the same quarter last year, and up 21.2% sequentially over the March 2026 quarter.

The company reported a net loss of ₹12 crore, against a net loss of ₹11 crore in the same quarter last year. Earnings per share (EPS) came in at ₹-0.64.

Operating profit stood at ₹7 crore — an operating margin (OPM) of 3.1%, compared with 2.4% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Camlin Fine Sciences Limited posted revenue of ₹838 crore, a decline of 5.5% over FY25, with a net loss of ₹33 crore.

On a trailing-twelve-month (TTM) basis, revenue stands at ₹869 crore with a net loss of ₹35 crore.

Valuation snapshot

At the current price of ₹95.09, CAMLINFINE has a market capitalisation of ₹1,827 crore.

Within the Chemicals industry, it is the 25th-largest of the 79 companies we track by market value.

Shareholding pattern

As of Sep 2026, promoters held 48.03%, foreign institutional investors (FIIs) 0.95%, domestic institutional investors (DIIs) 5.32%, public shareholders 45.70% of Camlin Fine Sciences Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹1,827 Cr
Current Price ?
₹95.1
P/E ?
N/A
Industry P/E ?
24.60
P/B ?
1.97
P/S ?
2.10
P/FCF ?
107.45
Enterprise Value ?
₹2,309 Cr
EV/EBITDA ?
46.14
PEG ?
N/A
Earnings Yield ?
-0.2%
Dividend Yield ?
0.00%
Profitability & Returns
Sales (TTM) ?
₹869 Cr
OPM ?
5.8%
Profit after tax (TTM) ?
₹-35 Cr
EPS (TTM) ?
₹-1.80
ROCE ?
2.0%
ROE ?
-3.7%
ROA ?
-2.0%
Growth
Sales — latest qtr ?
₹222 Cr
PAT — latest qtr ?
₹-12 Cr
YoY qtr sales growth ?
16.2%
YoY qtr profit growth ?
-15.3%
Sales growth (3y) ?
2%
Sales growth (5y) ?
7%
Profit growth (3y) ?
N/A
Profit growth (5y) ?
N/A
Financial Health
Debt ?
₹482 Cr
Debt to Equity ?
0.52
Interest Coverage ?
-0.1
Current Ratio ?
N/A
Ownership
Promoter holding ?
48.03%
Change in promoter holding ?
-1.06%
Pledged percentage ?
N/A
Market
Return 3 months ?
-22.5%
Return 6 months ?
-10.6%

🗓️ Quarterly results (15 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales 173218161206186220182227205273191244219184222 +16.2% +21.2%
Operating Profit 283425216-2671416335181967 +45.7% +13.5%
Other Income 11166262-93794106131 -62.0% -89.0%
Interest 121312151314141817171119152213 +18.0% -39.3%
Depreciation 81112121213131313131313141314 +0.8% +1.7%
Profit Before Tax 19117-1-18-49-18-111-712-16-4-17-17-19 -14.0% -12.3%
Net Profit 1686-1-12-44-14-73-616-11-4-13-6-12 -15.3% -117.9%
EPS 1.010.440.36-0.09-0.70-2.65-0.82-4.34-0.330.83-0.57-0.19-0.78-0.29-0.64 -12.3% -120.7%
OPM % 15.9% 15.7% 15.6% 10.4% 3.2% -11.6% 3.8% 6.2% 8.0% 12.2% 2.4% 7.5% 8.7% 3.3% 3.1% +29.2% -6.1%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹886 Cr ₹838 Cr ₹869 Cr -5.5%
Operating Profit ₹71 Cr ₹48 Cr ₹50 Cr -32.2%
OPM % 7.96% 5.72% 5.76% -28.1%
NPM % -8.61% -3.93% -3.98% +54.4%
Other Income ₹-76 Cr ₹32 Cr ₹30 Cr +142.7%
Depreciation ₹53 Cr ₹54 Cr ₹54 Cr +2.2%
Interest ₹66 Cr ₹67 Cr ₹69 Cr +1.3%
EBIT ₹18 Cr ₹-6 Cr ₹-4 Cr -132.0%
PBT ₹-123 Cr ₹-54 Cr ₹-56 Cr +56.2%
Tax ₹-9 Cr ₹-10 Cr ₹-11 Cr -10.1%
Net Profit ₹-76 Cr ₹-33 Cr ₹-35 Cr +56.8%
EPS ₹-4.66 ₹-1.83 ₹-1.90 +60.7%
Material Cost ₹391 Cr ₹326 Cr ₹373 Cr -16.8%
Employee Cost ₹53 Cr ₹58 Cr ₹60 Cr +9.5%
Extraordinary Items ₹-97 Cr ₹14 Cr ₹14 Cr +114.1%

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 16171919 +0.0%
Reserves 626699843910 +7.9%
Borrowings 617511458482 +5.2%
Other Liabilities 335345309361 +16.8%
Total Liabilities 1,5941,5721,6291,772 +8.8%
Fixed Assets 583577569526 -7.6%
CWIP 2831923 +155.6%
Investments 8280102217 +112.7%
Other Assets 9018849491,007 +6.1%
Total Assets 1,5941,5721,6291,772 +8.8%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 19822244 +100.0%
Cash from Investing Activity -115-52-88-30 +65.9%
Cash from Financing Activity 78-34101-13 -112.9%
Net Cash Flow -18-4350 -100.0%
Free Cash Flow -11341017 —
CFO/OP 19%286%29%93% +220.7%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 243232171207 +21.1%
Inventory Days 252210200199 -0.5%
Days Payable 248234203258 +27.1%
Cash Conversion Cycle 246208167147 -12.0%
Working Capital Days 1091139495 +1.1%
ROCE % 11%0%4%2% -50.0%

👥 Shareholding (latest 5 periods)

Metric Jun 2025Sep 2025Dec 2025Mar 2026Sep 2026 % Chg
Promoters 49.09%49.08%48.03%48.03%48.03% +0.0%
FIIs 2.88%2.11%2.12%0.94%0.95% +1.1%
DIIs 4.14%5.48%7.77%7.70%5.32% -30.9%
Government 0.00%0.00%0.00%0.00%— —
Public 43.88%43.33%42.07%43.31%45.70% +5.5%
No. of Shareholders 59,53857,66152,35752,23256,981 +9.1%

⚖️ Peer comparison

Industry: Chemicals · top 25 of 79 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 NAVINFLUOR Navin Fluorine ₹8,545.00 43,843 55.4 3,634 790 33.9% 21.7% 41.1% 130.1% 44.1% 107.7%
2 DEEPAKNTR Deepak Nitrite ₹1,596.00 21,768 27.8 8,575 784 15.5% 9.1% -4.8% -22.5% 36.4% 207.4%
3 DEEPAKFERT Deepak Fertilisers ₹1,323.00 16,718 17.0 12,103 985 16.7% 8.1% 12.0% -21.8% 22.5% 101.0%
4 TATACHEM Tata Chemicals ₹615.00 15,668 — 15,120 -1,971 11.3% -13.0% -2.0% -543.2% 14.4% -81.0%
5 PCBL PCBL Chemical ₹331.50 13,043 43.3 6,596 298 13.4% 4.5% -12.5% -46.0% 17.0% 64.8%
6 JUBLINGREA Jubilant Ingrevia ₹647.25 10,208 33.3 4,651 308 13.4% 6.6% 5.1% 10.3% 25.3% 40.9%
7 ALKYLAMINE Alkyl Amines ₹1,818.60 9,301 41.3 1,658 225 20.6% 13.5% -2.3% -3.8% 30.1% 93.1%
8 CLEAN Clean Science ₹820.00 8,715 37.4 982 232 35.7% 23.6% -2.5% -13.7% 21.9% -4.7%
9 GNFC Gujarat Narmada ₹539.75 7,931 7.6 8,410 1,037 14.8% 12.3% -1.5% 35.3% 39.8% 275.9%
10 GALAXYSURF Galaxy Surfactants ₹2,156.30 7,887 21.6 5,752 353 10.4% 6.1% 24.3% -50.0% 39.4% 108.7%
11 NEOGEN Neogen Chemicals ₹2,403.50 7,221 180.9 926 36 16.6% 3.8% 10.9% -17.6% 34.0% 66.8%
12 BALAMINES Balaji Amines ₹2,215.00 7,177 35.3 1,523 211 21.4% 13.9% 2.0% 6.5% 27.2% 113.9%
13 FCL Fineotex Chemical ₹53.07 6,180 41.6 1,012 148 16.7% 14.6% 44.8% 14.5% 174.8% 92.6%
14 ACI Archean Chemical ₹470.90 5,814 61.0 1,123 95 20.3% 8.5% 7.8% -37.0% 8.9% -24.4%
15 GULFOILLUB Gulf Oil ₹1,057.20 5,235 13.9 4,367 371 12.6% 8.5% 11.7% -3.4% 30.6% 27.0%
16 FOSECOIND Foseco India ₹6,846.50 5,186 64.7 618 77 17.5% 12.5% 12.2% -1.9% 9.2% 8.9%
17 GUJALKALI Gujarat Alkalies ₹696.50 5,115 77.0 4,497 66 11.2% 1.5% 7.0% 96.3% 12.6% 499.0%
18 LXCHEM Laxmi Organic ₹178.50 4,961 40.2 3,117 123 8.2% 4.0% -4.7% -43.4% 44.1% 194.8%
19 VISHNU Vishnu Chemicals ₹724.90 4,880 32.6 1,694 150 15.5% 8.8% 11.1% 12.2% 24.9% 23.0%
20 YASHO Yasho Industries ₹4,028.70 4,857 84.9 939 57 19.5% 6.1% 24.0% 771.1% 54.9% 801.3%
21 EPIGRAL Epigral ₹1,084.00 4,677 17.3 2,626 271 22.2% 10.3% -0.9% -7.2% 16.3% -37.9%
22 TATVA Tatva Chintan ₹1,867.60 4,369 85.0 556 51 19.3% 9.2% 32.6% 702.6% 42.8% 128.3%
23 GHCL GHCL ₹418.85 3,839 7.4 3,043 525 23.0% 17.3% -3.7% -23.5% -2.7% 31.8%
24 PREMEXPLN Premier Explosives ₹685.10 3,685 110.0 349 34 6.8% 9.6% -7.0% 60.5% -27.8% -80.2%
25 CAMLINFINE Camlin Fine ₹101.23 1,945 59.5 1,865 29 5.6% 1.6% 4.6% 133.0% 22.7% -214.8%
❓ Frequently asked questions
What was Camlin Fine Sciences Limited's revenue in Q1 FY27?
Camlin Fine Sciences Limited reported revenue of ₹222 crore for the quarter ended June 2026 (Q1 FY27), up 16.2% from ₹191 crore in the same quarter last year, and up 21.2% sequentially over the March 2026 quarter.
What was Camlin Fine Sciences Limited's net profit in Q1 FY27?
The company reported a net loss of ₹12 crore, against a net loss of ₹11 crore in the same quarter last year. Earnings per share (EPS) came in at ₹-0.64.
What is CAMLINFINE's market capitalisation and P/E ratio?
At the current price of ₹95.09, CAMLINFINE has a market capitalisation of ₹1,827 crore.
Who owns Camlin Fine Sciences Limited? (shareholding pattern)
As of Sep 2026, promoters held 48.03%, foreign institutional investors (FIIs) 0.95%, domestic institutional investors (DIIs) 5.32%, public shareholders 45.70% of Camlin Fine Sciences Limited.
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI